ANXA1 and Alzheimer disease: ANXA1 further appeared as a protective agent in Alzheimer’s disease by affecting amyloid-β clearance, following our recent report that ANXA1 reduced amyloid-β levels in vitro by increasing both microglial uptake and its enzymatic degradation in neurons.24